Information Security At Pfizer Case Summary

Information Security at Pfizer Darren Welch, Director of Information Security at Pfizer Pharmaceuticals where he drives a worldwide data security program and leads site data assurance programs at more than 200 offices. In his 18 years at Pfizer, he served the organization at various designations which includes the Threat Intelligence and Incident Response group, Computer Forensic operations, managing data assurance methods and technology, conveying counter-undercover work and general data security planning, formulating security strategies, and performing data security audits. Before his corporate experience, Darren was in Law Enforcement and the US Army Reserves.
Pfizer gathers individual data interacting with them. For the most part, Pfizer …show more content…
The data is also gathers from general public to understand the public point and view and cater the needs according to the demands of the general public. The company uses the personal information to maintain a log of queries made by the customers, to facilitate the individuals with its products and services, to access the public with developments and advancement in pharmaceutical methods, to create awareness among individuals about the medical remedies and cures and disseminate information about the healthcare issues which help individuals to take preventive measure in a proactive manner. Pfizer has instructed its staff that individual data must be managed as per the company's Policy and kept secure from unapproved access or divulgence. The access to individual data to Pfizer work force will be provided on a need to know basis. The staff has been trained about the obligation to ensure security and respect to this Policy (Anderson & Choobineh, …show more content…
Securities and Exchange Commission (SEC) filings to mirror the new typical in cybersecurity. The Big Pharma lays out the circumstance doubtlessly: "As a worldwide pharmaceutical organization, our frameworks are liable to continuous assaults." That announcement is one of three noteworthy changes to Pfizer's latest danger variable area on IT, the word check of which has dramatically increased since 2011. Other Big Pharma organizations have additionally extended the scope of IT security dangers they convey to financial specialists. In any case, the perception that being a worldwide pharmaceutical organization places Pfizer in line for "successive assaults" is not a concern, regardless of the fact that the announcement itself is obvious (Anderson & Choobineh,